| NTBIX | STBDX | NTBIX / STBDX | |
| Total Expense Ratio | 1.03 | 2.61 | 39% |
| Annual Report Gross Expense Ratio | 1.05 | 2.61 | 40% |
| Fund Existence | 12 years | 7 years | - |
| Gain YTD | 2.168 | 1.109 | 195% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 25000 | 10000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.14B | 1.23B | 581% |
| Annual Yield % from dividends | 4.12 | 4.85 | 85% |
| Returns for 1 year | 5.18 | 3.32 | 156% |
| Returns for 3 years | 18.41 | 10.29 | 179% |
| Returns for 5 years | 10.46 | 5.06 | 207% |
| Returns for 10 years | 33.24 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AFRU | 10.99 | 0.45 | +4.26% |
| T-REX 2X Long AFRM Daily Target ETF | |||
| LFSC | 47.80 | 0.35 | +0.75% |
| F/m Emerald Life Sciences Innovation ETF | |||
| MDYV | 95.71 | 0.57 | +0.60% |
| State Street® SPDR® S&P 400™ Md CpValETF | |||
| CPSF | 26.50 | N/A | N/A |
| Calamos S&P 500 Str Alt Prt ETF-Feb | |||
| IBTO | 23.76 | -0.04 | -0.19% |
| iShares iBonds Dec 2033 Term Trsy ETF | |||